Friday, July 13, 2018

Cingulate raises $7.5m for controlled-release ADHD therapy ... - Mass Device


Kansas City Business Journal

Cingulate raises $7.5m for controlled-release ADHD therapy ...
Mass Device
Cingulate Therapeutics said today that it landed a $7.5 million investment to help fund the development of its controlled-release ADHD drugs. The Kansas ...
Cingulate lands $7.5 million from ChemWerth founder - Kansas City ...Kansas City Business Journal
Cingulate Therapeutics Announces $7.5M Equity Investment from ...PR Newswire (press release)

all 3 news articles »

No comments:

Post a Comment